Discover FiteBac®

FiteBac is at the forefront of antimicrobial technology, a firm grounded in scientific rigor, backed by international scientists, and evidenced through numerous scientific publications and clinical trials.

Here’s why FiteBac stands out in the biotech landscape:

Patent-Protected Innovations:

FiteBac holds a robust portfolio of composition of matter patents in key markets including the U.S., Europe, and China, protecting its groundbreaking silsesquioxanes, elastomers, and drug technologies.

FDA Recognitions and Clearances:

FiteBac has secured FDA recognition for its new molecular entity, the K21 QAS drug, a topical antimicrobial solution, and has FDA clearances for its medical devices, demonstrating our commitment to meeting the highest standards of safety and efficacy.

Global Presence and Collaborative Endeavors:

FiteBac is not just a company but a globally recognized entity, having presented its innovative solutions at the world’s largest dental conference, IDS 2021 in Germany.

Moreover, FiteBac has forged strategic partnerships with industry leaders like RDAbbott and Siltech to develop materials with broad antimicrobial properties.

A Vision for a Healthier World:

At its core, FiteBac is driven by a mission to make the world a healthier place, leveraging its antimicrobial technology to foster well-being across communities globally.

As we stand on the cusp of a revolution in antimicrobial technology, FiteBac Pharma invites you to be a part of this journey, a journey towards a safer, healthier future, a journey paved with innovation, collaboration, and a steadfast commitment to improving lives.

Join us, as we shape a healthier tomorrow, today.


Composition of matter patents maintained in U.S., Europe, China

U.S. patents granted – silsesquioxanes, elastomers, drug

Trademarks received U.S., Europe, China, India, and Brazil


FDA recognition of NME (new molecular entity)
FDA Drug Master file K21 QAS DRUG

FDA NDA 128706 K21 QAS DRUG Topical Antimicrobial

FDA cleared medical devices

FDA Device Master file with K21 QAS

FDA Device Master file with K18 QAMS


Press Releases

FiteBac Presents in Germany at International Dental Show

U.S.-Based FiteBac Presents in Germany for First Time at International Dental Show, IDS2021, to Feature New Antimicrobial Additives for Dental Restorative MaterialsSummary: FiteBac will be a new, featured presenter at the world’s largest dental conference, IDS 2021,...

read more